Felicitas Pipkin felicitast5811
  • Tiri
  • http://47.105.50.196/karinaluisini
  • Results from the TRAVERSE trial were submitted in 2023, concluding that there was no increase in the risk of adverse cardiovascular outcomes in men using testosterone for hypogonadism.

  • Joined on 2026-04-03
Updated 2026-04-03 05:51:11 +08:00